Stifel Financial’s Definium Therapeutics DFTX Stock Holding History

Stifel Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$575K	Sell	12,225 -401	-3%	-$9.91K	﹤0.01%	2892
2026 Q1	$239K	Buy	+12,626	New	+$214K	﹤0.01%	3322
2022 Q2	–	Sell	-3,316	Closed	-$56K	–	3417
2022 Q1	$56K	Buy	3,316 +233	+8%	+$4.04K	﹤0.01%	3302
2021 Q4	$64K	Buy	3,083 +84	+3%	+$2.68K	﹤0.01%	3293
2021 Q3	$105K	Buy	2,999 +16	+0.5%	+$692	﹤0.01%	3238
2021 Q2	$154K	Buy	+2,983	New	+$157K	﹤0.01%	3188

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Stifel Financial's DFTX Position: Q2 2026 in Review

Stifel Financial reduced its Definium Therapeutics (DFTX) stake by 3.2% in Q2 2026, selling an estimated $9.91K and leaving 12,225 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Stifel Financial first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Stifel Financial held 12,225 shares of Definium Therapeutics worth $575K as of Q2 2026.
Stifel Financial sold 401 Definium Therapeutics shares in Q2 2026, an estimated $9.91K.
Definium Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2892 holding.
Stifel Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.